Loading
Latest filing published 06 Oct 2022 for Panbela Therapeutics, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Michael T. Cullen in Panbela Therapeutics, Inc., where the filings describe the role as board member. We count 9 filings; the first trade dates from 24 June 2016 and the latest from 4 October 2022.
On the market, this insider has only ever bought: 7 purchases. The totals do not cover 7 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant. Since January 2022: 1 purchase and no sales on the market.
Most recently, on 6 October 2022, the filings show an open-market purchase in Panbela Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations